Balyasny Asset Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
FLAM
RSCM
PAMP
Balyasny Asset Management's XENT Position: Q2 2021 in Review
Balyasny Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 300,103 shares — an estimated $6.27M sold.
Balyasny Asset Management first reported a position in XENT in Q3 2015 and held it in 13 quarters. The position peaked at $9.21M in Q4 2020. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.
- Balyasny Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
- Balyasny Asset Management sold 300,103 Intersect ENT, Inc shares in Q2 2021, an estimated $6.27M.
- Balyasny Asset Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 13 quarters.
- Balyasny Asset Management's Intersect ENT, Inc position peaked at $9.21M in Q4 2020.
- 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.
Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.